Global Ganja Report

In an outrageous case in France, the admitted perpetrator in an anti-Semitic murder will not stand trial, and will be going to a drug rehab facility instead of prison—on the basis of his claim of temporary insanity due to cannabis use. French Jewish leaders are of course aghast. But the decision also sets an alarming precedent in the fight for cannabis normalization—legitimizing the dubious notion of cannabis-induced psychosis, and further entrenching the stigma.

California is moving toward adopting official "appellations" for cannabis, certifying a strain's regional origin. The concept is inspired by the wine industry, where such a certification system has long been in place in several producer countries. Wine appellations, often a mark of prestige, provide a model for what is now to be applied to high-end cannabis.

Albania is pledging another one of its endless and fruitless cannabis eradication campaigns, which never succeed in bumping the country from its spot as Europe's biggest illicit producer. The US is pressing the small Balkan nation for the campaign—and kicking in military aid.

The horrific case of an elderly Jewish woman in Paris killed in a clear anti-Semitic attack is being painted as an incidence of "cannabis delirium." Despite all the progress since the days of Reefer Madness in the 1930s, cannabis is still  blamed for violent crime by law enforcement and media alike. Such irrational ugliness has also been repeatedly seen in the cases that have inspired Black Lives Matter on our side of the Atlantic.

Both the absurdity of the war on drugs and the depravity of the current administration in Washington are illustrated by the maddening case of Alvin Queen, an internationally acclaimed jazz drummer who was denied entry to the US due to a minor drug arrest when he was still a teen—despite the fact that he was born in the country!

France will introduce a law by year's end to end prison terms for cannabis use, a spokesman for the new President Emmanuel Macron said May 26. Macron made his pledge to reform laws on cannabis use a key campaign plank during the hard-fought race. Under current law, offenders can face a year in prison plus a fine of up to 3,750 euros ($4,200).

It seemed pretty fortuitous for Donald Trump. He left heads scratching when he told a crowd of supporters at a rally in Florida on Feb. 18: "You look at what’s happening in Germany, you look at what's happening last night in Sweden. Sweden! Who would believe this? They took in large numbers [of refugees]. They’re having problems like they never thought possible." A nice play to anti-immigrant hysteria, but there was one hitch: nothing had happened in Sweden the previous night. Critics had a field day with the bizarre flub, with Swedish activists even holding a mock "Pray for Sweden" vigil to taunt Trump. So it seemed a godsend for the prez when an immigrant district of Stockholm exploded into riots just three days later.

There is no end to false Internet rumors concerning our favorite herb, and the latest was just called out by those dogged rumor-busters at Snopes. It seems that Britain's Sky News of Jan. 13 reported on a clinical trial of an experimental drug in France that went horribly wrong, leaving one brain-dead and another three with what could be permanent brain damage. A total of 90 were given then new painkiller compound manufactured by the Portuguese pharma firm BIAL in a test overseen by UK-based Biotrial. The original Sky News account (as quoted by Snopes) refered to the compound as "cannabis-based." Currently, it only says that French Health Minister Marisol Touraine "denied reports the drug was based on the compound found in cannabis." But it got around before the text was changed, popping up on e-mail lists and social media.